MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic Infection

Approximately 370 million people worldwide are chronically infected with hepatitis B virus (HBV). Despite the success of the prophylactic HBV vaccine, no therapeutic vaccine or other immunotherapy modality is available for treatment of chronically infected individuals. Clearance of HBV depends on ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Comber, Joseph D., Karabudak, Aykan, Shetty, Vivekananda, Testa, James S., Huang, Xiaofang, Philip, Ramila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058288/
https://www.ncbi.nlm.nih.gov/pubmed/24971174
http://dx.doi.org/10.1155/2014/860562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058288/
https://www.ncbi.nlm.nih.gov/pubmed/24971174
http://dx.doi.org/10.1155/2014/860562

Ejemplares similares